+ All Categories
Home > Documents > 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub...

3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub...

Date post: 26-Aug-2020
Category:
Upload: others
View: 3 times
Download: 0 times
Share this document with a friend
31
61 3.1 INTRODUCTION Despite a control over bacterial colonization due to improved materials, implants, clean room techniques as well as systemic chemo prophylaxis, infection still remains a complication during injuries to skin. Conventional dressings form a natural barrier to the migrating epidermal cells, forcing them to move beneath the drying eschar, thus prolonging healing time and loss of healthy tissue. Further, use of these types of dressings, in cases like partial thickness burns, can result in progressive dehydration followed by devitalization and necrosis. The coagulum which forms after applying such type of dressings eventually dries up to form a difficult eschar, which is hard to remove and causes further trauma when removed (Thomas 1990). An ideal wound dressing is one, which induces host cells to regenerate, prevents infection, acts like an osmotic regulator providing optimal environment for healing to take place quickly (Varghese et al 1986, Ho et al 2001). The modern dressing materials available, such as films, hydrogels and other bioactive materials have their own merits and demerits. For instance hydrogels exhibit tendency to adhere due to simple intrinsic viscosity and stickiness of serum itself. When such a type of dressing is removed, the band between the eschar and the underlying tissue will fail first, resulting in considerable damage to newly formed epithelia. On the other hand, film dressings, by virtue of their semi permeable nature, are claimed to provide a barrier to bacteria as well complying with most of the ideal characteristics needed for an effective wound dressing (Drake 1984).
Transcript
Page 1: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

61

3.1 INTRODUCTION

Despite a control over bacterial colonization due to improved

materials, implants, clean room techniques as well as systemic chemo

prophylaxis, infection still remains a complication during injuries to skin.

Conventional dressings form a natural barrier to the migrating epidermal

cells, forcing them to move beneath the drying eschar, thus prolonging

healing time and loss of healthy tissue. Further, use of these types of

dressings, in cases like partial thickness burns, can result in progressive

dehydration followed by devitalization and necrosis. The coagulum which

forms after applying such type of dressings eventually dries up to form a

difficult eschar, which is hard to remove and causes further trauma when

removed (Thomas 1990). An ideal wound dressing is one, which induces host

cells to regenerate, prevents infection, acts like an osmotic regulator providing

optimal environment for healing to take place quickly (Varghese et al 1986,

Ho et al 2001). The modern dressing materials available, such as films,

hydrogels and other bioactive materials have their own merits and demerits.

For instance hydrogels exhibit tendency to adhere due to simple intrinsic

viscosity and stickiness of serum itself. When such a type of dressing is

removed, the band between the eschar and the underlying tissue will fail first,

resulting in considerable damage to newly formed epithelia. On the other

hand, film dressings, by virtue of their semi permeable nature, are claimed to

provide a barrier to bacteria as well complying with most of the ideal

characteristics needed for an effective wound dressing (Drake 1984).

Page 2: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

62

Infection in wounds greatly impairs the wound healing process

leading to chronicity of the wounds. A technical approach to control infection

can be through the delivery of antibacterial/ antibiotics at the site of wound.

There is an enormous advancement in developing wound care products

capable of mitigating infection. Amongst which, collagen is of special interest

due to its versatile structure and ability to interact with cells and proteins

during wound repair. Collagen films, by virtue of their capability to regulate

release profiles of incorporated drugs, have been used widely as carrier

constructs (Rubin et al 1973, Sato et al 1996, Thacharodi and Rao 1996).

Thus it has added new dimension to the design of biomaterial-based delivery

systems. Currently only a few collagens based dressings incorporated with

active therapeutic agents capable of controlling infection during healing

process are developed (Shanmugasundaram et al 2006). Considering the

ability of such types of dressings to control the release profiles of drugs, as in

excessive burns, plastic surgeons prescribe such appropriate temporary

dressings to the wound site in order to reduce bacterial infection and sepsis.

Products are available commercially, which utilize collagen as carrier

material for local antibacterial/ antibiotic delivery. In these systems

therapeutic agents are either delivered by spreading the drug in the form of

powder (Ruszczak and Friess 2003, Rushton 1997), by direct conjugation of

drug to amino or carboxyl terminal of the collagen membrane or through

microcarriers (Rao 1995, Raghunath et al 1985, Steffan et al 1985, Rossler

et al 1995, Maffia 1994). Collagen is also used for designing protein delivery

and gene delivery systems (Fujioka et al 1995, Honma et al 2004, Zhang et al

Page 3: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

63

2006). The systems mentioned above are intended to deliver therapeutic

moieties to modulate particular phase of wound healing like infection,

inflammation, re-epithelialization or remodeling. The remodeling event,

which is mainly carried out by MMPs are seldom targeted. Especially MMP-2

and MMP-9 are important as they are expressed in both early and late phases

of remodeling. The importance of MMPs during healing and their modulation

in response to inflammatory and infection status were investigated (Beckett et

al 1996). Hence the development of a delivery system, which can positively

modulate MMP activity, is of great significance.

In general MMP inhibitors (MMPI) developed so far are towards

cancer therapy or for control of arthritis (Brown 1998, Drummond et al 1999).

Whereas very few MMPIs that control the enzyme levels in tissue injury are

reported. Doxycycline, a tetracycline antibiotic, is one of the well-reported

MMPIs. Its sub antimicrobial dose has been reported to inhibit MMPs in

chronic periodontitis (Choi et al 2004), but its application targeting MMPs in

skin injury is not reported.

Figure 3.1 Structure of doxycycline hyclate

Page 4: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

64

In order to develop a controlled release system, a wide variety of

polymers are available. Among them biopolymers like chitosan, alginate, and

gelatin are preferred. Chitosan (poly (β-(1, 4)-2- amino-2-deoxy-D-

glucopyranose), a cationic polysaccharide, derived by deacetylation of chitin

is of special interest. The polyaminosaccharides in contrast to other polymers

carry a positive charge and are mucoadhesive in nature (Hirano et al 1988,

Issa et al 2005). The excellent biocompatibility and wide availability render

them ideal for drug delivery systems. Chitosan spheres prepared using a

covalent cross linker like glutaraldehyde is so far available (Thanoo et al

1992, Jameela et al 1996, Genta et al 1997, Blanco et al 2000). Due to

reported toxicity of glutaraldehyde, alternative methods of microsphere

preparation like spray drying (Lorenzo et al 1998, Mi et al 1999) and ionic

gelation using Na2SO4 or tripolyphosphate are carried out (Berthold et al

1996, Calvo et al 1997). In the present study, chitosan microspheres are

prepared by ionic gelation through potassium hydroxide (KOH) as

crosslinking agent. The spheres are prepared by a w/o emulsion technique and

are further utilized to entrap doxycycline hyclate by equilibrium swelling

method. The drug entrapped in the spheres is further impregnated into the

shark skin collagen scaffold.

The design and development of wound dressing, which could combat

both infection and elevated MMP levels through unit dosage application, is

indeed a novel approach to promote accelerated healing. In cases of severe

infection the local concentration of the administered antibiotic through

systemic route may not be sufficient to control the infection. Therefore,

Page 5: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

65

topical antimicrobial therapy remains one of the most important methods of

skin wound care. The local application of antibiotics can provide high drug

concentrations at the site of infection and would avoid systemic effects (Park

et al 2004). The design encompasses development of shark skin collagen Aloe

scaffold impregnated with doxycycline loaded chitosan microspheres. The

morphological characteristics of scaffolds are analyzed through light

microscopy and scanning electron microscopy. The current investigation also

provides design validation for percentage doxycycline entrapment, its in vitro

release profile from the scaffold and distribution homogeneity of impregnated

spheres. Hence this work describes the development and characterization of

reconstituted shark skin collagen scaffold impregnated with doxycycline-

loaded chitosan microspheres, capable of delivering the drug in a controlled

manner.

3.2 MATERIALS

Doxycycline hyclate, Soya oil and low viscosity grade Chitosan

(75-85% deacetylation, Mr: 90000-100000) were obtained from Sigma,

USA.Span-80 was obtained from Fluka, Switzerland; n-octanol was procured

from Merck, Germany. Trypsicase Soy Broth (TSB) Trypsicase Soy Agar

(TSA), Mueller Hinton Broth (MHB) and Mueller Hinton Agar (MHA) were

obtained from HI-MEDIA, India Ltd., Mumbai. All other chemicals used in

this work are of analytical grade. Microbial cultures - Pseudomonas

aeruginosa (ATCC 25619), Staphylococcus aureus (ATCC 9144), Klebsiella

pneumoniae (ATCC 15380) and E.coli (ATCC 25922) were obtained from

IMTECH, Chandigarh.

Page 6: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

66

3.3 METHODS

3.3.1 Preparation of chitosan microspheres

Chitosan microspheres (CSM) were prepared by novel water in oil

(w/o) emulsification process with simultaneous ionic coacervation technique.

A w/o emulsion of chitosan was prepared by slowly adding 6 ml of 3% w/v

chitosan (in 0.5 M acetic acid) to a mixed oil phase containing 30 ml of soya

oil and 60 ml of n-octanol. Span 80, 5% v/v was used as an emulsifier. The

mixture was emulsified using a magnetic stirrer and an overhead stirrer

simultaneously. The stirring speed of the overhead stirrer was maintained at

1600 - 1700 rpm, while magnetic stirrer was maintained at 1000 rpm,

throughout the process of microsphere preparation. Stirring was continued for

1 h until a stable w/o emulsion was obtained. Ionic gelation was initiated by

slow, drop-wise addition of 1% w/v of KOH (1.5 ml / 15 min for 4 h) in

n-octanol. After crosslinking, the oil phase of the mixture containing chitosan

microspheres was slowly decanted and the spheres were immediately added to

100 ml of acetone. The washing was repeated twice with acetone until

discrete spheres free from oil phase were obtained. The recovered spheres

were dried in a vacuum desiccator. The microspheres were optimized

according to the process variables listed in Table 3.1

3.3.2 Determination of particle size distribution and swelling ratio

A particle size analyzer (Malvern Mastersizer E – Laser, UK) was

used to determine the particle size distribution of chitosan microspheres. The

particles were analyzed at focal length of 300 mm by using Isopropyl alcohol

Page 7: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

67

(IPA) as a non-dissolving and non-reacting dispersion medium. The samples

were kept at constant stirring using a magnetic cell stirrer till completion of

analysis in order to maintain homogenous and discrete distribution of the

spheres. The swelling ratio of chitosan microspheres was determined using

Malvern diffraction particle size analyzer (Malvern Mastersizer E – Laser,

UK). To determine the swelling capacity of CSM, a known amount of

microspheres (25 mg) was dispersed in deionized water and change in

the size of microspheres at appropriate time intervals was determined.

Table 3.1 Variables involved in preparation of chitosan microspheres

S. No. Process Parameters Variables Involved

1. Soya oil: n-octanol ratio 2:1, 1:1, 1:2, 1:3, 1:4 & 1:5

2.

Percentage of emulsifier (Span 80)

3, 4, 5, 6 and 7 % v/v

3.

Percentage v/v of 3 % w/v chitosan in 0.5 M acetic acid

4, 5, 6 and 7 % v/v

4. Overhead stirrer speed 1600, 1800, 2000 and 2200 rpm

5. Percentage v/v of KOH in n-octanol

1%, 2% and 3%

The measurements were carried out at 15 min time interval for 1 h,

then at every 1 h until 6 h. After which, measurements were carried out at

doubling time interval until 48 h. The swelling ratio was calculated from the

ratio of size of swollen particles at various time intervals to that of dry

spheres.

Page 8: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

68

3.3.3 Entrapment of doxycycline in chitosan microspheres

Doxycycline was entrapped in chitosan microspheres (Doxy-CSM)

by equilibrium swelling method. To the aqueous solution of doxycycline

(5 mg/ ml), various amount of CSM were added in ratio of 1:5, 1:10, 1:15,

1:20 % w/w of doxycycline: CSM and allowed to swell under mild rocking

condition for 90 min after which the supernatant solution was decanted and

the residual spheres were collected, dried using a centrifugal drier (SpeedVac,

SPD 111v, Thermo Savant, USA) until constant weight was obtained.

Percentage entrapment of doxycycline was determined by the equation,

100xloaddrugInitial

spheresofamountknownindrugofAmountEntrapmentDrug% =

The amount of doxycycline was assessed spectrophotometrically

(Perkin Elmer lambda 45) at the wavelength of 267 nm by dissolving an

exactly weighed amount of loaded microspheres in 1 ml of 6N HCL at 600C

for 1 h. Before determining the drug concentration photometrically, the assay

mixture was centrifuged at 4000 rpm for 15 min and supernatant was

separated out from residual chitosan.

3.3.4 Morphological analysis

The morphological features of CSM and Doxy-CSM were assessed

by both light microscopic and scanning electron microscopic (SEM)

techniques. The light microscopic images were taken using LEICA DMIRB

microscope, Leica Wetzlar, Germany to observe the bulk morphology. The

Page 9: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

69

ultra structural features were analyzed by JEOL JSM – 5610 series scanning

electron microscope, equipped with electron optical system (EOS) consisting

of 0.5 - 30 kV capacity electron gun and an electron detector. Before the

samples were analyzed they were spurt coated with gold using a JEOL

JFC-1600 Auto fine coater.

3.3.5 Biocompatibility of chitosan microspheres

Fibroblasts were seeded (2 x 104 cells / well) into 24 well plate with 1

ml of culture medium and incubated (Thermo Forma, USA) overnight for

attachment of cells at 370C in 5 % CO2, 95 % air atmosphere. Doxy-CSM

equivalent to the concentration of 100-500 μg of the drug and same

concentration of doxycycline were added to the respective wells and

incubation continued for 48 h. After incubation, 50 μl of MTT (3-3-(4, 5-

dimethylthiozole-2-yl)-2, 5-diphenyltetrazolium bromide) solution (5 mg /

ml) was added to each well and incubated for 4 h at 370C (Mosmann 1983).

After which medium containing microspheres was removed gently and 500 μl

of dimethylsulfoxide (DMSO) was added to solubilize the formazan complex

and read in a micro plate reader (BIORAD, Model 680, USA) at 570 nm.

The % cell viability relative to control was calculated by [A] test / [A]

control x 100. Control was maintained same as above but omitting

doxycycline and Doxy-CSM. Values reported are the mean of 3

determinations.

CSM was further evaluated for its ability to act as a scaffold for

fibroblasts by allowing the cells to migrate into the microspheres and viewing

Page 10: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

70

the cells by calcein AM fluorescent dye. CSM was added in duplicates to a 24

well plate containing fibroblasts (2 x 104 cells / well) with 1ml of culture

medium and incubated for 96 hours in 5 % CO2, 95 % air atmosphere. After

which, to each well, 0.2 μM of calcein AM was added and incubated for

20 min. CSM were transferred into eppondorf tube and excess of calcein AM

was removed by washing with 500 μl of PBS. Few drops of CSM suspension

in PBS was dropped in cavity slide and viewed under phase contrast

fluorescent microscope (Leica DMIRB, USA). Photomicrographs were taken

to visualize the metabolically active cells inside the CSM using blue filter.

3.3.6 In Vitro Antibacterial activity of Doxy-CSM

Antibacterial activity of the drug-loaded spheres was examined

against Pseudomonas aeruginosa (ATCC 25619), Staphylococcus aureus

(ATCC 9144), Klebsiella pneumoniae (ATCC 15380), and E. coli (ATCC

25922). Initial inoculums of these strains were prepared by inoculating five

colonies from fresh cultures (overnight cultured) in TSB for S. aureus,

K. pneumoniae, and E. coli, and in MHB for Pseudomonas aeruginosa,

incubated at 35°C till logarithmic growth phase. From this culture, 100 µl of

the sample was transferred to 10 ml of respective media and incubated at

35°C to attain exponential logarithmic phase (≡ 0.5 McFarland). The cultures

were appropriately diluted to get 5x107 cfu / ml and used as primary inoculum

(NCCLS 2000). Different amounts of Doxy-CSM containing drug

concentration equivalent to 10-100 µg per ml was introduced into the flasks

containing various cultures and incubated at 35°C for 72 hours. Samples were

Page 11: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

71

withdrawn at different time intervals to determine the minimal bactericidal

concentration (MBC) (99.9% kill from initial inoculums) and mean number of

survivors at MBC.

3.3.7 Evaluation of doxycycline as MMP inhibitor by gelatin

zymography

Post burn granulation tissue (Day 7) was collected from human burn

patients after prior consent, complying with the ethical guidance of Central

Leather Research Institute (CLRI) and Kilpauk Medical College and Hospital

(KMCH), Chennai. Tissue was washed 4 times with water and then with

20 mM HEPES buffer (pH 7.5) to remove adhering blood clot and other

debris. The tissue was then homogenized for 2 min in buffer solution (50 mM

Tris-HCl, pH 7.5) on ice bath, centrifuged (SIGMA 3K30, USA) at

10,000 rpm, 40C for 15 min and the supernatant was collected, aliquoted and

stored at – 700C.

Granulation tissue lysate (containing 20 mg of protein) was incubated

alone (control) as well as with various concentrations of doxycycline for 15 h

at 37oC. The incubated samples were mixed with non-reducing laemmli’s

sample buffer and electrophoresed using a 7.5% PAGE containing 0.1%

gelatin substrate. Standard MMP 2 and MMP 9 activated by

4-aminophenylmercuric acetate (APMA) buffer (0.5 mM APMA, 50 mM Tris

HCl, pH 7.5, 50 mM NaCl, 0.005% Triton X-100), were simultaneously

electrophoresed. After electrophoresis, the gel was washed with 2.5% Triton

X-100 for 1 h and then incubated with enzyme buffer (50 mM of Tris-HCl,

Page 12: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

72

150 mM NaCl, 5mM CaCl2 and 0.05% sodium azide) at 370C for 20 h to

allow reactivation of MMPs. Gels were then stained with 0.5% Coomassie

Brilliant Blue R-250 (Fredericks and Mook 2004) and destained with 10% v/v

of acetic acid containing 30 % v/v of methanol. The MMPs were visualized as

clarified bands corresponding to zones of digestion of substrate gelatin.

3.3.8 Preparation of doxycycline-loaded microspheres impregnated

shark skin collagen – Aloe scaffold

For scaffold development, a known amount (300mg) of shark skin

collagen (PSC) was dissolved in 25 ml of 0.05 M acetic acid and 30mg

equivalent weight of Aloe extract was added as described in chapter 2. Fibril

formation was initiated by adding appropriate amount of 0.2 M phosphate

buffer (2ml), 2M NaCl and adjusting the pH using 1M sodium hydroxide to

6.9 – 7.2, until turbidity appeared. To the collagen solution a known amount

(0.2 grams) of drug loaded microspheres was added and gently stirred to

distribute the spheres homogeneously throughout the solution. After fibril

initiation the viscous solution was uniformly cast over horizontally placed

polypropylene platforms of 10x10cm dimension. The scaffolds were then

allowed to dry at a constant temperature of 300C until a thin scaffold was

obtained. The scaffold was stored in a light proof desiccator for further

experimental purpose.

Page 13: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

73

3.3.9 Determination of distribution homogeneity of microspheres in the

scaffold

To determine whether the drug-loaded microspheres are distributed in

a homogenous fashion, equal contours of 2x2 cm were cut randomly from

different regions of drug impregnated scaffolds and were subjected to drug

analysis by UV-Spectrophotometer and the amount of drug incorporated in

each contour was determined.

3.3.10 Morphological assessment of microspheres impregnated collagen

scaffolds

The surface and cross sectional features of doxycycline loaded

microspheres impregnated collagen scaffold (Doxy-MS-CS) were assessed

through both light microscope and SEM (with the same instruments as used to

analyze microspheres). Light microscopic images were taken to examine the

bulk property of the spheres in the scaffold, while SEM images were taken to

obtain information regarding the features of each microsphere and their mode

of entanglement with the collagen fibrils.

3.3.11 In Vitro release studies

The in vitro release study was carried out using the Franz diffusion

model finite dosage apparatus as schematically illustrated in Figure 3.2 (Franz

1978). A 12.5 cm2 of microspheres-impregnated scaffold was placed over the

aperture of Franz apparatus (Shanmugasundaram et al 2006) and subjected to

release rate experiment under constant stirring, using a magnetic stirrer, at

Page 14: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

74

370C. The reservoir solution of the Franz apparatus contained physiological

synthetic serum electrolyte solution (SSES, composed of 0.601g of NaCl,

0.235g of NaHCO3, 0.0283g of Na2HPO4, and 0.0284g of Na2SO4 / 100mL)

(Tsipouras et al 1995). To determine the release characteristics, aliquots of

samples were withdrawn at regular time intervals (3, 6, 12, 24, 48 and

72 hours) and analyzed for the amount of doxycycline released using

UV – spectrophotometer at 267nm. The experiments were carried out in

triplicate and the amount of drug released was expressed as % drug released

with respect to time.

Figure 3.2 Diagrammatic representation of Franz diffusion apparatus

Page 15: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

75

3.4 RESULTS

3.4.1 Preparation of chitosan microspheres

Chitosan microspheres were prepared by w/o emulsification process

with simultaneous ionic coacervation technique. In this process a mixture of

oil phase (soya oil and n-octanol) was used since it provided continuous phase

of optimal Relative Hydrophilic Lipophilic Balance (RHLB) to form uniform

aqueous phase chitosan micelles, which eventually transform into rigid

spheres, without any agglomeration. The oil mixtures of various ratios were

used for different batches of microsphere preparation. Oil mixture ratio of 2:1,

1:1, (soya oil : n-octanol) caused spheres of irregular morphology. In these

ratios, chitosan spheres obtained were discrete, but the high viscosity gradient

of soya oil had certain impact on surface morphology. The spheres appeared

sickle due to leaching of soya oil through the pores during recovery. However

oil mixture ratio of 1:2 (soya oil : n-octanol) resulted in formation of porous

microspheres without affecting the morphology of microspheres. Further

enhancement of n-octanol, resulted in the aggregation of spheres.

Due to low RHLB of oil phase mixture, Span 80 with low HLB (4.7)

was used. A 5% v/v of span 80 was found to be optimal to form microspheres

of uniform surface morphology with the size range of 200 - 225 μm, below

which aggregation of spheres occurred. Span 80 at 6 and 7% v/v causes

discrete spherical microspheres with the size range of 150-200 μm and

75-180 μm respectively. The most critical step in preparation of microsphere

is percentage w/v of chitosan used for preparation of spheres. Earlier studies

Page 16: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

76

(Janes et al., 2001) showed that concentration of chitosan below 3% w/v

results in coacervates of weak structures, which are susceptible to breakage

during the process of agitation. Hence, 3% w/v of chitosan prepared in 0.5 M

acetic acid was used in various concentrations. The 6% v/v of chitosan

solution was found to yield spheres of desirable size (200-225 μm) and

morphology. When volume of chitosan was increased to 7% v/v, the spheres

aggregated and strongly bound to each other, with the size range of

200-350 μm. Below 6% v/v discrete spheres were obtained, but they were

found to be fragile and some of the spheres disintegrated into smaller

particles. Moreover, with lower concentrations of chitosan the size of the

spheres varied widely. To obtain microspheres of uniform size and spherecity,

different batches of spheres were prepared at various speeds. The spheres

prepared with 1600 rpm was >95% uniformly sized and discrete.

Microspheres prepared with 1800 rpm resulted in formation of discrete

spheres with >50% size variation. Batch experiments carried out with speed

>2000 rpm resulted in heavily undersized (<100 μm), while those <1600 rpm

yielded agglomerated and oversized spheres (>300 μm). Hence the speed

range 1600-1700 rpm was used for further optimization and microsphere

preparation.

Crosslinking of microspheres was carried out using potassium

hydroxide. In order to improve the crosslinking it is essential that the anions

move uniformly from the core of the spheres to surface of matrix. In most of

the cases aqueous anionic solutions are used, but this resulted in crosslinking

of surface at faster rate than the core accounting for uneven crosslinking and

Page 17: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

77

formation of fragile structures. Hence in this process KOH was dissolved in

n-octanol at various concentrations by sonication and batch experiments were

carried out individually. With 3% w/v of KOH, spheres adhered to the vessel

walls and more than 25% polymer settled down as jelly matrix. Batches

prepared with 2% w/v of KOH resulted in much better yield of spheres (>85%

recovery), but surface aggregation was inevitable. Hence the process was

validated with 1% w/v of KOH, which resulted in matrix congealing in a

uniform manner with >95% recovery of spheres in 200-225 μm size. The rate

and volume of addition of KOH was also considered equally important. Slow

crosslinking by drop wise addition at the rate of 1.5 ml/ min of 1% KOH at

every 15 min time interval was found to be optimal. Total time consumed to

obtain rigidized spheres was 4 h and final process of collection involves slow

and complete recovery of microspheres from oil phase using acetone. The

spheres with above conditions were found to be ideal and the spheres obtained

were of uniform size with spherical morphology and were completely

rigidized.

3.4.2 Particle size distribution and swelling ratio

The particle size distribution curve (Figure 3.3) shows sharp

distribution range of microspheres, with 90% spheres of 208 μm size and only

10% were undersized (<150 μm). To assess the ability of chitosan

microspheres to swell, 25 mg was placed in deionized water and increase in

size was assessed through particle size analysis at regular time intervals. A

plot of the swelling ratio with respect to time (Figure 3.4) shows that the

Page 18: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

78

Figure 3.3 Particle size distributions of chitosan microspheres

1

1.2

1.4

1.6

1.8

2

0 0 .25 0 .5 0 .75 1 2 3 4 5 6 12 24 48

Time (h)

Swel

ling

Rat

io

Figure 3.4 Swelling ratio of chitosan microspheres determined by

Malvern particle size analyzer

Page 19: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

79

microspheres were able to swell 1.59 fold than the original size in 1 h and

remained in equilibrium for 6 h. After which, only a slight increase (≈ 2%) in

size occurred for 48 h. The spheres retained their morphology throughout the

study, without any disruptions.

3.4.3 Doxycycline entrapment

Maximum percentage entrapment of doxycycline was observed at

1:10 % w/w Doxycycline: CSM and found to be 8.4 % w/w. At higher

concentration (as detailed in methods) there was no significant increase in

percentage entrapment. Higher amount of CSM with respect to drug did not

show any significant improvement in entrapment efficiency.

3.4.4 Morphological features of CSM and Doxy-CSM

The chitosan microspheres exhibited typical characteristic features of

an ionically crosslinked coacervated matrix. Figure 3.6.a shows the light

microscopic images, of spheres with uniform size and shape. The SEM

images (Figure 3.6.b and Figure 3.6.c) further confirmed the uniformity and

also showed the porous nature of the microspheres due to interconnecting

network of chitosan. Light microscopic image of Doxy-CSM (Figure 3.6.d)

indicated that the spheres did not loose their morphology after entrapment.

SEM images confirmed further that the porous nature is retained after drug

loading (Figures 3.6.e and 3.6.f).

Page 20: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

80

3.4.5 Biocompatibility

The biocompatibility of the doxycycline and Doxy-CSM was

demonstrated by performing MTT assay. The free doxycycline showed dose

dependant inhibition of fibroblast growth and the drug concentration beyond

200 μg, was found to be toxic to the cells (Figure 3.5). The drug-loaded

microspheres did not show any toxicity even at 400 µg.

0

20

40

60

80

100

120

Control Doxycycline Doxy-CSM

% C

ell v

iabi

lity

100 200 300 400 500

Figure 3.5 MTT assay of human dermal fibroblast, treated for 48 h

with free doxycycline and doxycycline loaded chitosan

microspheres

Page 21: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

81

(b)

(c)

(e)

(d) (a)

(f)

Figure 3.6 Morphological features of chitosan microspheres and doxycycline loaded chitosan microspheres. Photomicrograph (a) (20x) shows uniformly sized spheres with smooth surface. The SEM image (b) and (c) show the porous nature of the chitosan microspheres. Photomicrograph (d) is light micrographic image of Doxy-CSM taken at 20x. SEM images of Doxy-CSM (e) and (f) show that the morphological features of the microspheres are maintained after entrapment

Page 22: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

82

a

* *

*

b

The fluoroprobe Calcein AM was used to indicate the ability of CSM

to act as a scaffold for fibroblasts. Calcein AM is a membrane permeant,

non-fluorescent molecule, once inside the cells it is hydrolyzed by

endogenous esterases into green fluorescent calcein and retained in the

cytoplasm of the live cells (Figure 3.7.a). During the study the cells were

observed to migrate towards the microspheres and penetrated through the

pores of the microspheres rather than spreading over the entire culture

surface. The fluorescent photomicrographs (Figure 3.7.b) of CSM exposed to

the fibroblasts for 96 h, showed deeply embedded metabolically active cells in

CSM. The study reveals that the developed CSM is a good substratum and

can be utilized as a scaffold for various biomedical applications.

Figure 3.7 Fluorescent photomicrograph of fibroblast cultured over cover slip as well as with chitosan microspheres. a) Shows the green fluorescence of the cytoplasm of the spindle shaped viable cells after treatment with calcein AM (2μM) for 20 min. b) Photomicrograph showing deeply embedded fibroblasts as fluorescence in chitosan microspheres (indicated by asterisk), focused beyond the boundaries of the microspheres). The inset of the figure (20x) is the image at normal focus

Page 23: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

83

3.4.6 Antibacterial activity

Antibacterial efficiency of the Doxy-CSM was assessed by

determining the MBC by standard tube dilution method against four standard

pathogenic strains (ATCC) in mid-logarithmic phase cultures. The MBC was

found to be nearly equal for Klebsiella pneumoniae (16.5 µg/ ml) and E. coli

(17.4 µg/ ml). Pseudomonas aeruginosa required higher drug concentrations

(98.3 µg/ ml), while Staphylococcus aureus exhibited susceptibility (MBC)

with lesser concentration levels (11.2 µg/ ml). Though the number of

survivors observed varied with different time points, they were found to be

well within the susceptibility limits (20-300 cfu).

3.4.7 MMP inhibition activity of doxycycline

Gelatin zymography was carried out with extracts of human post-burn

granulation tissue, as a source of MMPs. Lane 1 in Figure 3.8 is the standard

enzymes of human MMPs 2 & 9 activated by APMA. Lane 2 shows the

MMPs in the granulation tissue extracts, in which active form of MMP 2 and

MMP 9 are major enzymes expressed. It can be clearly seen that there is a

concentration dependent inhibition of MMPs (lane 3-6) by doxycycline and

complete inhibition (lane 5) was achieved at 95 μg concentration of

doxycycline.

Page 24: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

84

3.4.8 Determination of distribution homogeneity of microspheres in the

scaffold

In order to find whether impregnated microspheres in collagen

scaffold are evenly distributed, randomly cut, equally sized (2 x 2 cm)

contours of specific area of microsphere-impregnated scaffolds were

subjected to drug analysis. The drug content was found to be 196 ± 9 μg and

there was no significant difference observed among the samples. Hence they

show great deal of homogeneous distribution pattern.

Figure 3.8 Gelatin zymogram showing MMP inhibitory effect of doxycycline with extracts of human post-burn granulation tissue. Lane 1 is the standard enzyme, MMP 2 and MMP 9. Lane 2 shows the MMPs expressed in the granulation tissue extracts in which active form of MMP 2 and MMP 9 are major enzymes expressed. Lane 3, 4, 5 and 6 show the inhibition of MMPs with increasing concentrations of

doxycycline 80 μg, 90 μg 95 μg and 100 μg respectively.

Page 25: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

85

3.4.9 Morphological assessment of microspheres impregnated collagen

scaffolds

The surface property of the microspheres impregnated collagen

scaffold when observed through LM (Figure 3.9a) shows rough surface with

ridges and furrows due to the entanglement of spheres into the network of

collagen fibrils. Figure 3.9b shows the SEM image exhibiting the surface

morphology of microsphere impregnated collagen scaffold, where spheres are

entangled in the fiber network and the interconnecting pores between fiber

attachments to the microspheres can be seen. At high magnification

(Figure 3.9c) the overlaid microspheres entangled with the collagen fibrils can

be observed. The SEM image (Figure 3.9d) of section cut in transverse to the

surface of collagen scaffold shows microspheres impregnated within the

porous interconnecting collagen fibril assembly.

3.4.10 In Vitro release studies

The in vitro drug release experiments were carried out using Franz

diffusion apparatus. This was used to obtain a ‘finite dose’ setting and to more

closely simulate the average clinical situation in which the therapeutic agent

is applied to the injured skin. To simulate the in vivo ionic environment,

synthetic serum electrolyte solution (SSES) was used as a sink medium

(Tsipouras et al 1995). In this condition release of doxycycline can be directly

estimated at 267 nm in SSES. From Figure 3.10, it can be observed that after

6 hours around 38.0% of drug is released. This initial burst is a characteristic

feature of an ionically cross-linked chitosan microsphere and is preferable

Page 26: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

86

a

d

b

c

Figure 3.9 Morphological features of doxycycline loaded chitosan

microspheres impregnated collagen scaffold

since it is mandatory that any application intended to control burn wound

infection needs to exert immediate chemo prophylaxis. Subsequent analysis of

released drug shows that around 62.0% drug was released in 12 hours and

71.0%, 81.0% and 83.0% of drug release were observed in 24, 48 and 72-hour

time intervals respectively. There was a remarkable increase in drug release

between 12-24 hours after which equilibrium concentration was achieved and

maintained until 72 hours with little increase in percentage release.

Considering practical aspects, it is appropriate if the dressing is able to deliver

doxycycline in a controlled fashion for minimum of 3 days. This reduces the

Page 27: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

87

frequency of dressing changes in comparison to conventional cream based

therapy, which requires daily attention.

Figure 3.10 In vitro release profile of doxycycline from chitosan

microspheres in synthetic serum electrolyte solution (SSES),

pH 7.4, at 370C

3.5 DISCUSSION

Design of any biological or synthetic dressing has to be carried out

with realization that any skin wound requires a barrier application to prevent

infection and desiccation and guide cells of dermal elements to maximize

healing. Collagen has gained remarkable application as a natural constituent

of connective tissue. Main goal of this study is to design a shark skin collagen

scaffold, which can prevent infection for prolonged time and positively

modulate MMPs as well as provide active space for tissue regeneration.

Page 28: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

88

Doxycycline possesses the ability to bind with divalent metal ions to

cross the tissue barrier. This phenomenon finds application to inhibit MMPs

by sequestering Zn2+ (Ryan et al., 2001). This is an important reason to select

doxycycline as an antibiotic especially in cases of chronic wounds prone for

infection. Previous reports show that doxycycline reduces proteolytic

degradation of substrate in a dose dependent manner, giving a clear indication

of its ability to elicit therapeutic efficiency in a narrow range (Vachon and

Yager 2006).

Chitosan was selected as the carrier material to deliver doxycycline,

since it is a unique polycationic polymer with excellent biocompatibility and

biodegradable characteristics. Chitosan forms films and gels with strong and

integrated matrix when it reacts with anionic/ polyanionic compounds. Anions

like citrates and tripolyphosphates (TPP) are effective cross linkers as they

carry more than two negatively charged sites, but microspheres possess a

fragile matrix (Shu and Zhu 2002). In this novel process chitosan was

ionically crosslinked using KOH, (dissolved in n-octanol by sonication),

which enables the ions to reach the core of the micelles, without affecting

their shape. The oil phase component, n-octanol, does not cause instability to

emulsion throughout the process. Rather they enable the ions to get deposited

throughout the micellar sites and get distributed in the continuous phase.

Usage of oil phase crosslinking also obviates immediate surface crosslinking,

which otherwise results in fragile matrix. Slow crosslinking is induced, thus

resulting in uniform matrix crosslinking from core to the surface. The

morphological features observed by SEM analysis provides evidence for the

Page 29: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

89

above fact which also proves that by adopting the present protocol spheres of

uniform size can be obtained with high percentage recovery (> 95%). The

process variables like speed of emulsification, crosslinking rate and % w/v of

chitosan used are key variables in obtaining spheres of desired range.

Amongst all variables, concentration of chitosan is extremely important and

low % of chitosan causes weak structures. A 6% v/v of chitosan was found to

provide microspheres of stable porous structure with uniform size (> 90%

between 200 – 225 μm) and shape. Chitosan microspheres swelled ≈ 1.5 fold

of their original size and maintained spherical morphology indicating the

intact nature of crosslinked matrix.

The current investigation demonstrated that doxycycline when

entrapped in CSM, could give clear demarcation in susceptibility

concentration. It has been reported that doxycycline exhibits MBC of 30 µg

(www.pfizer), where as controlled release requires a total drug concentration

of 98.3 µg. The amount of microspheres impregnated in collagen scaffold was

calculated in accordance to highest bacterial susceptibility concentration (with

respect to Pseudomonas aeruginosa in our current investigation).

It is well known that during fibril formation inter cross-links of

helical chains occur rather than the interaction of fibers with the

microspheres. During drug release, interconnecting pores will increase in

diameter when it swells, so that the spheres get released from network rather

than being adhered to the matrix. Hence release of doxycycline would purely

depend on swelling of collagen and diffusion controlled release through

Page 30: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

90

chitosan microspheres. Care was taken to produce a homogenous distribution

to maintain the drug concentration uniform throughout the wound surface.

The process of drug release is dependent on two rate-limiting steps,

• Swelling of the porous network of collagen and

• Diffusion through porous chitosan matrix.

Depending on level of hydration and equilibrium concentration of

doxycycline, further release will occur.

The initial burst release rate (38%) exerts immediate chemo

prophylaxis and subsequent equilibrium concentration maintenance in a

controlled manner for antibacterial susceptibility. The above aspect and the

homogenous distribution to cover the entire area of wound surface during

application were found to be crucial steps in designing the current system to

deliver doxycycline in a controlled fashion for a period of 3 days thus

reducing the frequency of dressing.

Another important aspect in controlling the release of the drug is to

reduce the host cell toxicity. Doxycycline when used as pure drug caused

significant decrease in cell viability beyond 200 µg where as equimolar

concentration in Doxy-CSM does not induce toxicity. Moreover fluorescent

assay shows CSM to act as template in inducing cell migration and

proliferation.

Page 31: 3.1 INTRODUCTIONshodhganga.inflibnet.ac.in/bitstream/10603/4563/9/09_chapter 3.pdf · Its sub antimicrobial dose has been reported to inhibit MMPs in chronic periodontitis (Choi et

91

Hence the present study provides scope for using doxycycline at

intended therapeutic range for both MMP inhibition as well as controlling

infection without inducing any host tissue damage. Previous reports

demonstrated that doxycycline induces positive modulation of MMP at sub -

antibiotic concentration (Choi et al 2004). This is important in cases of

chronic diseases where elevated enzyme levels are seen. Doxy-CSM may

provide moist environment for healing as well as deliver the drug at required

concentration to control infection and further release of doxycycline may be

reduced or arrested when exudation decreases. The MMP inhibition study

further confirms that doxycycline concentration required to kill pathogens

would be sufficient to control MMPs. This would enable the system to

prevent matrix degradation and induce positive tissue healing. Further, the

system developed provides wider scope to control the pathogens involved in

infection and excess matrix degradation.


Recommended